Health
New nanoimmunoassay can detect anti–SARS-CoV-2 antibodies in ultralow-volume blood samples – News-Medical.Net
In a recent study, researchers developed and validated a nanoimmunoassay (NIA) that analyzes 1,024 samples in parallel on a single microfluidic device the size…
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been the largest global public health crisis in recent memory. To date, it has been responsible for over 158.3 million infections and over 3.3 million deaths the world over.
Managing this crisis, mitigating viral spread, and planning to prepare for the next phase of the pandemic involves numerous testing and analysis regimes. Continuous monitoring of the virus spread…
-
Noosa News23 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News24 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General21 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News18 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project